XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Restatement of Previously Issued Unaudited Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2018 (Tables)
9 Months Ended
Sep. 30, 2018
Accounting Changes and Error Corrections [Abstract]  
Schedule of Restatements

The following table presents the effect of the restatements on the Company’s previously issued balance sheet:

 

    As of September 30, 2018  
    As Previously Reported     Adjustments     As Restated  
                   
Note receivable   $ 6,300,000     $ (6,000,000 )   $ 300,000  
                         
Additional paid-in capital     17,736,192       (1,360,000 )     16,376,192  
                         
Accumulated deficit     (3,887,080 )     (4,640,000 )     (8,527,080 )

 

The following table presents the effect of the restatements on the Company’s previously issued statement of operations:

 

    For the three months ended September 30, 2018  
    As Previously Reported     Adjustments     As Restated  
                   
Fair value of common stock issued in connection with the financing transaction   $ -     $ 4,640,000     $ 4,640,000  
                         
Net loss     (132,586 )     (4,640,000 )     (4,772,586 )
Net loss attributable to common shareholders     (213,200 )     (4,640,000 )     (4,835,200 )
Comprehensive loss     (288,052 )     (4,640,000 )     (4,928,052 )
Net loss per share, basic and diluted   $ (0.00 )   $ (0.09 )   $ (0.09 )

 

    For the nine months ended September 30, 2018  
    As Previously Reported     Adjustments     As Restated  
                   
Fair value of common stock issued in connection with the financing transaction   $ -     $ 4,640,000     $ 4,640,000  
                         
Net loss     (506,255 )     (4,640,000 )     (5,146,255 )
Net loss attributable to common shareholders     (620,767 )     (4,640,000 )     (5,260,767 )
Comprehensive loss     (728,906 )     (4,640,000 )     (5,368,906 )
Net loss per share, basic and diluted   $ (0.01 )      (0.09 )   (0.10 )

 

The following table presents the effect of the restatements on the Company’s previously issued statement of cash flows:

 

    For the nine months ended September 30, 2018  
    As Previously Reported     Adjustments     As Restated  
                   
Cash flows from operating activities:                        
Net loss     (506,255 )     (4,640,000 )     (5,146,255 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Fair value of common stock issued in connection with the financing transaction     -       4,640,000       4,640,000  
                         
Issuance of notes receivable     (6,300,000 )     6,000,000       (300,000 )
Net cash provided by (used in) investing activities     (5,757,920 )     6,000,000       242,080  
                         
Proceeds from shares issued for cash     9,463, 705       (6,000,000 )     3,463,705  
Net cash provided by financing activities     8,008,063       (6,000,000 )     2,008,063